First Trust Advisors LP Acquires 8,173 Shares of Theralase Technologies Inc. (TLT)
First Trust Advisors LP grew its holdings in shares of Theralase Technologies Inc. (NASDAQ:TLT) by 12.7% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 72,623 shares of the company’s stock after acquiring an additional 8,173 shares during the period. First Trust Advisors LP’s holdings in Theralase Technologies were worth $9,060,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds have also modified their holdings of the company. Knowledge Leaders Capital LLC boosted its holdings in Theralase Technologies by 65.1% in the 3rd quarter. Knowledge Leaders Capital LLC now owns 5,413 shares of the company’s stock worth $675,000 after buying an additional 2,134 shares during the period. Summit X LLC lifted its stake in Theralase Technologies by 35.3% in the 3rd quarter. Summit X LLC now owns 3,787 shares of the company’s stock worth $436,000 after purchasing an additional 987 shares in the last quarter. Crow Point Partners LLC purchased a new stake in Theralase Technologies in the 3rd quarter worth $529,000. Eqis Capital Management Inc. lifted its stake in Theralase Technologies by 18.2% in the 3rd quarter. Eqis Capital Management Inc. now owns 107,832 shares of the company’s stock worth $13,453,000 after purchasing an additional 16,567 shares in the last quarter. Finally, Perigon Wealth Management LLC lifted its stake in Theralase Technologies by 10.7% in the 2nd quarter. Perigon Wealth Management LLC now owns 5,390 shares of the company’s stock worth $674,000 after purchasing an additional 520 shares in the last quarter.
Shares of Theralase Technologies Inc. (NASDAQ:TLT) opened at C$124.10 on Friday. Theralase Technologies Inc. has a one year low of C$116.49 and a one year high of C$129.57.
The firm also recently announced a monthly dividend, which was paid on Tuesday, November 7th. Stockholders of record on Thursday, November 2nd were given a dividend of $0.2631 per share. This represents a $3.16 annualized dividend and a dividend yield of 2.54%. This is a boost from Theralase Technologies’s previous monthly dividend of $0.25. The ex-dividend date of this dividend was Wednesday, November 1st.
Theralase Technologies Company Profile
iShares 20+ Year Treasury Bond ETF (the Fund) is an exchange-traded fund. The Fund seeks to track the investment results of an index composed of United States Treasury bonds with remaining maturities greater than 20 years. The Fund seeks to track the investment results of the Barclays U.S. 20+ Year Treasury Bond Index (the Underlying Index), which measures the performance of public obligations of the United States Treasury that have a remaining maturity of 20 or more years.
Want to see what other hedge funds are holding TLT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Theralase Technologies Inc. (NASDAQ:TLT).
Receive News & Ratings for Theralase Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Theralase Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.